The COVID-19 pandemic has spread worldwide for over 2 years now. The pandemic raises a significant threat to global health due to its transmissibility and high pathogenicity. The current standard detection method for COVID-19, namely, reverse transcription–polymerase chain reaction (RT–PCR), is slow and inaccurate to help fight the pandemic. RT–PCR takes hours to days to report a single test result and has a high false-negative rate. As a result, an infected person with a negative test result may unknowingly continue to spread the virus. Thus, better detection methods are required to improve the control of COVID-19. With technology advancements in artificial intelligence and machine learning, deep-learning diagnostic studies to detect COVID-19 infection using medical chest imaging have emerged. In this paper, we review these studies by analyzing their approaches and highlighting their major challenges. These challenges include dataset cleanness, public dataset availability, capability to differentiate COVID-19 from unrelated viral pneumonia, and the difficulty in dealing with images from multiple points of view. Finally, we discuss various ideas and solutions to address the highlighted challenges in the reviewed papers.
The COVID-19 pandemic has spread worldwide for over two years. It was considered a significant threat to global health due to its transmissibility and high pathogenicity. The standard test for COVID-19, namely, reverse transcription polymerase chain reaction (RT–PCR), is somehow inaccurate and might have a high false-negative rate (FNR). As a result, an infected person with a negative test result may unknowingly continue to spread the virus, especially if they are infected with an undiscovered COVID-19 strain. Thus, a more accurate diagnostic technique is required. In this study, we propose 3Cs, which is a capsule neural network (CapsNet) used to classify computed tomography (CT) images as novel coronavirus pneumonia (NCP), common pneumonia (CP), or normal lungs. Using 6123 CT images of healthy patients’ lungs and those of patients with CP and NCP, the 3Cs method achieved an accuracy of around 98% and an FNR of about 2%, demonstrating CapNet’s ability to extract features from CT images that distinguish between healthy and infected lungs. This research confirmed that using CapsNet to detect COVID-19 from CT images results in a lower FNR compared to RT–PCR. Thus, it can be used in conjunction with RT–PCR to diagnose COVID-19 regardless of the variant.